- Home
- BAP vs WST Comparison
BAP vs WST Comparison
Compare BAP & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAP
- WST
- Stock Information
- Founded
- BAP 1889
- WST 1923
- Country
- BAP Peru
- WST United States
- Employees
- BAP N/A
- WST N/A
- Industry
- BAP Major Banks
- WST Medical/Dental Instruments
- Sector
- BAP Finance
- WST Health Care
- Exchange
- BAP Nasdaq
- WST Nasdaq
- Market Cap
- BAP 14.5B
- WST 15.6B
- IPO Year
- BAP 1995
- WST N/A
- Fundamental
- Price
- BAP $211.97
- WST $211.06
- Analyst Decision
- BAP Hold
- WST Strong Buy
- Analyst Count
- BAP 3
- WST 6
- Target Price
- BAP $195.67
- WST $349.00
- AVG Volume (30 Days)
- BAP 327.0K
- WST 593.9K
- Earning Date
- BAP 05-15-2025
- WST 07-24-2025
- Dividend Yield
- BAP 6.50%
- WST 0.40%
- EPS Growth
- BAP 15.58
- WST N/A
- EPS
- BAP 19.76
- WST 6.37
- Revenue
- BAP $5,114,481,827.00
- WST $2,895,800,000.00
- Revenue This Year
- BAP $26.00
- WST $3.38
- Revenue Next Year
- BAP $5.93
- WST $5.85
- P/E Ratio
- BAP $10.72
- WST $33.08
- Revenue Growth
- BAP 14.82
- WST N/A
- 52 Week Low
- BAP $153.27
- WST $187.43
- 52 Week High
- BAP $212.93
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- BAP 64.56
- WST 48.29
- Support Level
- BAP $193.13
- WST $203.74
- Resistance Level
- BAP $210.71
- WST $213.84
- Average True Range (ATR)
- BAP 4.75
- WST 5.48
- MACD
- BAP 0.30
- WST 0.09
- Stochastic Oscillator
- BAP 95.46
- WST 45.56
About BAP Credicorp Ltd.
Credicorp Ltd is a Peruvian financial services company. It operates in four business lines including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.